Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function

BACKGROUND: In patients undergoing incident hemodialysis, increased fibroblast growth factor-23 (FGF-23) levels are associated with the development of cardiovascular disease (CVD), but the influence of residual kidney function (RFK) on this association is unclear. This study aimed to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kee, Youn Kyung, Jeon, Hee Jung, Oh, Jieun, Cho, Ajin, Lee, Young-Ki, Yoon, Jong-Woo, Kim, Hyunsuk, Yoo, Tae-Hyun, Shin, Dong Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368752/
https://www.ncbi.nlm.nih.gov/pubmed/37501787
http://dx.doi.org/10.3389/fendo.2023.1099975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368752/
https://www.ncbi.nlm.nih.gov/pubmed/37501787
http://dx.doi.org/10.3389/fendo.2023.1099975

Ejemplares similares